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Agarwood, which is used as medicine and incense, contains sesquiterpenes and chromones. 
Agarotetrol is a chromone derivative found in high concentrations in the water extract fraction of 
agarwood and thus may be present in pharmaceutical products made from decoctions of agarwood. 
Agarotetrol has been reported to be present at the early stages of cell death in calli. We therefore 
examined the presence of agarotetrol in medical- and incense-grade agarwood, in agarwood source 
plants lacking resin deposits, and in artificially made agarwood. Agarotetrol appeared as a large peak 
in the HPLC chromatograms of all samples of medical-grade and artificially made agarwood, and in 
most incense-grade agarwood samples. In contrast, agarwood samples lacking resin deposits did not 
contain agarotetrol. These results show that agarotetrol is characteristic of resin formation. Agarotetrol 
was also detected in decoctions of agarwood. A newly developed TLC method for the detection of 
agarotetrol in agarwood is described. 
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Introduction 
  The Japanese Standards for Non-pharmacopoeial Crude Drugs 2018 (Non-JPS 2018) [1] define 
agarwood as a resin deposited by some species of the genus Aquiralia. Agarwood is used as incense, 
and in Kampo formula such as chokoshiteito and zenshikunshito and household medicines such as 
rokushingan and kiohgan. 
 Generally, the agarwood used in incense and traditional medicine is distributed via different routes. 
Agarwood used as incense is more valuable than that used as medicine. Chromone derivatives, 
sesquiterpenes, and low molecular weight aromatic compounds are the principle ingredients in 
agarwood resin and give agarwood its scent [2,3,4]. Chromone derivatives do not readily volatilize 
and have no scent of their own, but sesquiterpenes are volatile and thus fragrant. Low molecular 
weight aromatic compounds such as benzylacetone are volatile and can be detected when agarwood 
is heated [5]. Agarotetrol (Fig.1) is a chromone and is involved in the production of low molecular 
weight aromatic compounds such as benzylacetone when agarwood is heated [6]. Agarotetrol is not 
believed to be present in the non-resinous part of the agarwood plant because low molecular weight 
aromatic compounds such as benzylacetone are not detectable when agarwood plants that lack resin 
deposits are heated [6]. In addition, agarotetrol and other chromones are not detected in healthy 
agarwood trees [3,6]. Studies of agarwood calli have shown that agarotetrol can be detected in the 
early stages of cell death in calli [7]. The presence of agarotetrol may indicate whether or not an 
agarwood plant contains deposited resin because it is absent in healthy agarwood plants and is likely 
produced during cell death. Agarotetrol is detected in large quantities in hot water extracts of 
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agarwood [6], suggesting that agarotetrol may be present in decoctions of Kampo prescriptions such 
as chokoshiteito and zenshikunshito. As noted above, the presence of agarotetrol can been used to 
determine the presence of agarwood resin, and agarotetrol is expected to be included in decoctions 
of agarwood. Accordingly, in this study we discuss the application of agarotetrol in component 
analysis and the quality evaluation of agarwood. 
 
Materials and methods 
 
Materials  
 Eight samples of medical-grade agarwood (M-1–M-8) which were distributed for medical use and 
five for use as incense (collected from Indonesia (I-1), Papua new Guinea (I-2), Bangladesh (I-3), 
Vietnam (I-4), India (I-5)) which were distributed for incense were prepared for analysis. Two samples 
of artificially made agarwood from cultivated trees were obtained from a market in Vietnam (samples 
A, B). A non-resinous sample was collected from an agarwood tree (Aquilaria sinensis) growing at 
the Experimental Station for Medicinal Plants at the Graduate School of Pharmaceutical Science, 
Kyoto University, and cut into small pieces to dry.  
 
Methods 
 Each sample of agarwood was cut into small pieces and crushed using a mortar and pestle with liquid 
nitrogen. The powdered samples (about 50 mg each) were transferred to screw cap tubes and volatile 
components were extracted with 5 mL diethyl ether for 24 h on a tube rotator. The diethyl ether extract 
was filtered through a filter paper (ADVANTEC 2, Toyo Roshi Kaisha, Ltd., Tokyo, Japan) to remove 
the residue, dehydrated with anhydrous sodium sulfate, and concentrated for GC and GC-MS analyses. 
The residue was extracted twice with 5 mL ethyl acetate for 24 h to extract non-volatile, poorly volatile, 
and non-polar compounds. The paper-filtered extracts were combined, concentrated to dryness, 
dissolved in MeOH (1 mg/ml) and filtered again (Cromatodisc 13P, 0.45 µm; GL Sciences, Tokyo, 
Japan), and then subjected to HPLC analysis. The residue was further extracted twice with 5 mL of 
distilled water for 24 h to extract non-volatile polar compounds. Following paper filtration, these 
extracts were combined, freeze-dried, dissolved in 20% MeOH (1 mg/ml) and filtered again, and then 
analyzed by HPLC. A decoction of medical-grade agarwood was prepared as follows. Sample was cut 
into small pieces and crushed using a mortar and pestle with liquid nitrogen. The powdered sample 
(1.50 g) were added to 600 ml of water in a covered glass jar and heated on an electric decoction 
apparatus (microcomputer decoction pot 2 HMJ-1000N (Hario, Tokyo, Japan) for 1 h. The decoction 
was filtered through a filter paper, freeze-dried, dissolved in 20% MeOH (1 mg/ml), filtered again, 
and subjected to HPLC analysis.  
 
GC analysis  
 Samples were analyzed using a G-5000 GC instrument (Hitachi, Tokyo, Japan) equipped with an 
InertCap-WAX column (60 m×0.25 mm, film thickness 0.25 µm; GL Sciences, Tokyo, Japan). The 
split ratio was 99:1. The conditions for GC analysis were as follows: carrier gas, helium; flow rate, 1 
ml/min; injector temperature, 230°C; flame ionization detector (FID) temperature, 250°C; column 
oven program, 100°C initially, then increased by 4°C per min to 180°C, maintained at 180°C for 30 
min, then increased by 5°C per min to 240°C, then maintained for 18 min; Injection volume, 3 μl. 
 
GC-MS analysis 
 Samples were analyzed on a GC-MS instrument (6850GC with 5975MDS, Agilent Technologies, 
Santa Clara, CA) equipped with a DB-WAX column (60 m × 0.25 mm, film thickness 0.25 μm, Agilent 
Technologies). The conditions for GC-MS analyses were as follows: carrier gas, helium; flow rate, 1 
ml/min; injector temperature, 230°C; column oven program 100°C initially, then increased by 4°C per 
min to 180°C, and maintained at 180°C for 30 min. The temperature was then increased by 5°C per 
min to 240°C and maintained for 18 min; injection volume, 1 μl. Peaks were identified by comparing 
the retention times and mass fragmentation patterns of the samples with the National Institute of 




 The HPLC system consisted of an L-7100 pump, L-7300 column oven, and an L-7420 UV detector 
(Hitachi, Ltd.). The conditions were as follows: 5C18MS-II (Cosmosil, Nacalai Tesque Inc. Kyoto, 
Japan) column, 4.6 mm I.D. × 250 mm; solvent, MeOH-water: 20% (0 min) → 30% (60 min) → 45% 
(80 min) → 64% (140 min) MeOH; flow rate, 1ml/min, injection volume, 10 μl; detection at 254 nm. 
Agarotetrol in the samples was identified by comparing peak retention times with the retention time 
of agarotetrol purified from agarwood. 
 
Isolation and quantification of agarotetrol 
 Freeze-dried hot water extract of agarwood in our previous paper [6] was also used in this report. 
Freeze-dried powder (61.52 mg) was dissolved in 20% MeOH (15 mg/ml) for fractionation. 
Conditions for fractionation by HPLC were as follows: 5C18MS-II (Cosmosil, Nacalai Tesque Inc.) 
column, 20 mm I.D. × 250 mm; solvent, MeOH-water; gradient from 20% (0 min) to 30% (120 min) 
MeOH; flow rate, 8 ml/min; detection at 254 nm. The amount of target compound obtained was 17.36 
mg.  1H- and 13C-NMR spectra of the isolated compound was measured on a 500 MHz spectrometer 
(JNMECA 500KP, Jeol Ltd., Tokyo, Japan). Compound was identified by comparing the data with 
those in the published literature [8].  
 The concentration of agarotetrol in each sample was calculated according to the peak area of 
agarotetrol on the HPLC chromatogram based on a calibration curve constructed using 1-, 10-, 100- 
and 1,000-μg/ml solutions of agarotetrol standard.  
 
TLC 
 Medical-grade agarwood (60 mg) was extracted with 2 mL MeOH by ultrasonication for 10 min and 
the extract was separated by filtration. Agarotetrol standard was dissolved in MeOH. Sample solutions 
were spotted on a TLC plate (TLC silica gel 60 RP-18 F254S; Merck Ltd., Tokyo, Japan) using a glass 
capillary, the plate was developed with a mixture of MeOH and water (1:1) to a distance of about 5 
cm, and air-dried. The spot corresponding to agarotetrol was examined under ultra-violet light (main 




 GC and GC-MS analysis 
 Table 1 shows the results of GC and GC-MS analyses of diethyl ether extracts of medical-grade and 
incense-grade agarwood. Sesquiterpenes reported previously as components of agarwood were 
detected in the diethyl ether extracts of agarwood for use as incense. No sesquiterpenes were detected 
in the diethyl ether extracts of medical-grade agarwood whereas compounds such as cinnamaldehyde 
and eugenol were detected. These compounds were likely contaminants from residual Cinnamon Bark 
and cloves stored together with the agarwood samples prior to our purchase of the samples [9,10].  
 
Weights of the extracts and HPLC patterns of each sample 
 Table 2 shows the weights of the ethyl acetate and water extracts of medical-grade agarwood, 
incense-grade agarwood, samples generated by treatment, and of a non-resinous sample. The average 
amount of extract detected in each solvent was generally higher in the incense-grade samples than in 
the medical-grade samples. However, the amount of extract from several medical-grade samples was 
higher than that from incense-grade samples, suggesting that the amount of extract is not always 
relevant to the grade of the sample.  
HPLC chromatograms of the extracts are shown in Fig. 2. All water extracts of medical-grade 
agarwood provided a large agarotetrol peak and agarotetrol was also detected in water extracts of 
incense-grade agarwood, but the chromatogram patterns differed, and some peaks were larger than the 
agarotetrol peak. Both samples of artificially made agarwood provided large agarotetrol peaks whereas 
both the ethyl acetate and water extracts of the non-resinous sample provided few peaks upon HPLC 
analysis. 
 
HPLC analysis of a decoction of medical-grade agarwood  
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 Agarotetrol was detected in a decoction of medical-grade agarwood (Fig. 3). Extraction of 1.50 g of 
medical-grade agarwood provided 63.17 mg extract which contained 805.4 μg of agarotetrol.  
 
Detection of agarotetrol on TLC 




 Resin deposition occurs in species of Aquilaria such as A. mallaccensis, in several Thymelaeaceae 
such as A. sinensis and A. crassna, and in Gyrinops species [11-15]. It was previously shown that the 
number of chromone derivatives increases as resin deposition is enhanced [3].  
 Previous studies using agarwood-calli showed that the amount of chromone derivatives increases as 
time course [16], and agarotetrol in particular was detected at early stages of cell death [7]. In the 
present study, agarotetrol was detected as a main peak in the HPLC profiles of commercial medical-
grade agarwood. Given that sesquiterpenes were not detected in such agarwood, and fewer HPLC 
peaks were observed in its ethyl acetate and water extracts compared with incense-grade agarwood, 
this medical-grade agarwood might be at an early stage of resin deposition.  
 
 GC, GC-MS, and HPLC analyses showed the presence of sesquiterpenes and the absence of 
agarotetrol in Papua New Guinea sample I-2. In addition, the amounts of water-soluble and ethyl-
acetate-soluble components were smaller than those from other agarwood samples. To our knowledge, 
there are no reports that only agarwood from Papua New Guinea has the above characteristics, 
although there are reports of differences in composition patterns in agarwood collected from different 
locations. Also, as described above, the pattern of chromone derivative components can change 
depending on the degree of resin deposition. Furthermore, various factors can be considered, such as 
the possibility that processed agarwood can be permeated with extract from other agarwood samples 
under pressure. Further discussion regarding the composition pattern of agarwood will require samples 
with traceable backgrounds, such as the original plant source and the number of years of resinification.  
 Cinnamaldehyde and eugenol were detected in diethyl ether extracts of medical-grade agarwood 
residue. These are likely contaminants transferred into the samples during lengthy storage in the same 
warehouse as crude drugs containing many volatile aromatic compounds, such as those found in 
cinnamon and clove [9,10].  
 Comparison of agarwood samples of various qualities obtained from markets requires knowledge 
of the composition of medical-grade agarwood. Shimada et al. reported a quantitative analysis of 
compounds in an acetone extract of agarwood [17]. They observed a rough correlation between the 
amount of acetone extract and the agarwood grade and a higher correlation between the amount of 
agarotetrol + isoagarotetrol and the grade of each agarwood sample. In the present study, we measured 
the amounts of ethyl acetate and water extracts of incense-grade and medical-grade agarwood and 
found that the amount of extract tended to be higher for incense-grade agarwood. However, we also 
observed variations between samples, with some medical-grade agarwood samples producing more 
extract than incense-grade samples. Additionally, the amount of water extract obtained from fresh 
plants lacking resin formation was very large, consistent with a previous report [18]. This result 
indicates that the weight of ethyl acetate or water extract alone is insufficient for quality evaluation.  
 The definition of agarwood in Non-JPS 2018 [1] includes the phrase "emits an aroma when heated". 
Low molecular weight aromatic compounds such as benzylacetone and benzaldehyde are detected 
when agarotetrol is heated [6]. Agarotetrol is thus a characteristic of agarwood and plays an important 
role in the quality evaluation of agarwood. Medical-grade agarwood is consumed orally in the form 
of a decoction when prescribed in Kampo medicines such as chokoshiteito and zenshikunshito. We 
prepared and analyzed a decoction of 1.50 g agarwood with 600 mL of water and found 805.4 μg of 
agarotetrol in the decoction. The pharmacological ingredients in agarwood decoctions remain 
unknown but agarotetrol, which is water-soluble, is likely one component. 
 TLC is a common identification method used in the Japanese Pharmacopoeia, Seventeenth Edition 
(JP17) [19] and Non-JPS 2018 to confirm the quality of crude drugs. Although the target analyte in 
the TLC test is currently unspecified in the section on the quality evaluation of agarwood, agarotetrol 
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is likely a useful indicator of quality because it was present at high concentration in all samples of 
medical-grade agarwood analyzed in this study and may be present in agarwood decoctions. TLC 
conditions previously used to separate agarotetrol in agarwood extract used chloroform [17,18,20]. 
However, there is a global trend away from solvents containing halogens due to environmental 
concerns, and the Japanese Pharmacopoeia also recommends avoiding solvents containing halogens 
as much as possible. The present study demonstrated the separation of agarotetrol without using 
chloroform. 
 The amount of wild agarwood is decreasing. Three genera reported to produce agarwood were listed 
in Appendix II of the Convention on International Trade in Endangered Species of World Fauna and 
Flora (CITES) in 2005 [21]. Consequently, farmers in agarwood-producing countries plant agarwood 
trees and artificially damage them to promote resin deposition. Previous studies reported the detection 
of chromone derivatives in artificial agarwood [22]. In this report, we also observed the deposition of 




Agarotetrol was present at high concentrations in all medical-grade samples tested and in agarwood-
decoction, but was absent in agarwood plants that lacked resin deposits. We also developed an easy, 
halogen-free TLC method to detect agarotetrol. Our findings show that agarotetrol is likely 
characteristic of medical-grade agarwood and can be used as an easily applicable index in quality 
evaluations of agarwood. 
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Fig. 2 HPLC chromatograms of water and ethyl ether extracts of agarwood. 
     Black arrow: Agarotetrol peak (in the water extract chromatogram) 
 
  
Fig.3 HPLC chromatogram of a decoction of medical-grade agarwood  
















Table 1 Compounds detected in diethyl ether extracts of agarwood 
 
*RI= retention index on a DB-WAX column  
‘-‘ signifies not detected 
Numbers are peak area% quantified by their FID peak area  
Original agarwood
lacking resin depositions
RI M-1 M-2 M-3 M-4 M-5 M-6 M-7 M-8 I-1 I-2 I-3 I-4 I-5 A B
Benzaldehyde 1469 - - - - - - - - - - 0.23 - - - - -
Valencene 1669 - - - - - - - - - 0.08 - - - - - -
(-)-α-Panasinsen 1693 - - - - - - - - - 2.26 - - - - - -
Anethole 1815 - - - 0.01 - 0.18 - - - - - - - - - -
Benzylacetone 1830 - - - - - - - - - - 0.28 - - 3.24 2.44 -
(E)-Cinnamaldehyde 2018 - 10.54 9.25 5.99 11.71 8.49 8.50 6.48 - - - - - - - -
8-epi-γ-Eudesmol 2051 - - - - - - - - - - 7.79 - - - - -
Eugenol 2076 - 11.85 23.77 12.10 19.08 37.90 - 6.10 - - - - - - - -
γ-Eudesmol 2082 - - - - - - - - - - 1.05 - - - - -
Hinesol 2090 - - - - - - - - - 0.07 - - - - -
α-Eudesmol 2208 - - - - - - - - - 1.20 - - - - -
β-Eudesmol 2212 - - - - - - - - 2.89 2.88 - - 3.57 - -
Incense-grade agarwood ArtificialMedical-grade agarwood
 Table 2  Weight% of agarwood ethyl acetate and water extracts 
 

























Artificial agarwood A 11.18 7.38
Artificial agarwood B 13.76 4.38
Without resin deposition 2.40 7.99
5.66
8.54
2.26
3.09
